RTW INVESTMENTS, LP Q1 2021 Filing
Filed May 14, 2021
Portfolio Value
$6.4B
Holdings
111
Report Date
Q1 2021
Filing Type
13F-HR
All Holdings (111 positions)
| Stock | Value |
|---|---|
RCKTRocket Pharmaceuticals Inc | $697.3M |
SPYSPDR S&P 500 ETF TR | $375.0M |
VCELVericel Corp | $251.0M |
PTCTPTC Therapeutics Inc | $250.7M |
ALNYAlnylam Pharmaceuticals Inc | $237.7M |
MRTXEURMirati Therapeutics Inc | $228.4M |
—Dicerna Pharmaceuticals Inc | $190.8M |
ILMNIllumina Inc | $185.1M |
NTRANatera Inc | $173.9M |
DMTKQDermTech Inc | $158.4M |
ESTAEstablishment Labs Hldgs Inc | $145.0M |
STOKStoke Therapeutics Inc | $141.5M |
3M4Masimo Corp | $136.6M |
TXG10x Genomics Inc | $128.8M |
CERNCHFCerner Corp | $127.5M |
AXNX*Axonics Modulation Technolog | $112.8M |
QDELUSDQuidel Corp | $112.4M |
ARVNArvinas Inc | $107.3M |
GMEDGlobus Med Inc | $103.0M |
IMVTImmunovant Inc | $102.0M |
TNDMTandem Diabetes Care Inc | $100.5M |
5E7Iteos Therapeutics Inc | $94.4M |
GHGuardant Health Inc | $93.1M |
AXSMAxsome Therapeutics Inc | $91.5M |
PTGXProtagonist Therapeutics Inc | $90.8M |
RNAAvidity Biosciences Inc | $87.1M |
TCE2Celldex Therapeutics Inc New | $80.5M |
CCCCC4 Therapeutics Inc | $79.4M |
TARSTarsus Pharmaceuticals Inc. | $79.1M |
ADVMCHFAdverum Biotechnologies Inc | $72.5M |
—Translate Bio Inc | $72.3M |
MGNXMacroGenics Inc | $64.2M |
IDYAIdeaya Biosciences Inc | $58.0M |
CSTLCastle Biosciences Inc | $54.7M |
RLMDRelmada Therapeutics Inc | $53.9M |
NSTGEURNanoString Technologies Inc | $52.8M |
AVDLAvadel Pharmaceuticals plc | $51.9M |
—Prometheus Biosciences Inc | $51.7M |
LUNGPulmonx Corp | $51.7M |
IMCRImmunocore Hldgs PLC | $50.1M |
—Athira Pharma Inc | $48.8M |
CYTKCytokinetics Inc | $46.5M |
PRQRProQR Thrapeutics N V | $42.5M |
OPHTEURIVERIC bio Inc | $41.5M |
—Curis Inc | $41.0M |
—Genetron Hldgs Ltd | $39.0M |
—Landos Biopharma Inc | $38.3M |
FULCFulcrum Therapeutics Inc | $37.8M |
AGENEURAgenus Inc | $37.5M |
OMGBPOutset Med Inc | $37.4M |
OYSTOyster Pt Pharma Inc | $34.0M |
APYXApyx Medical Corporation | $32.8M |
KURAKura Oncology Inc | $30.6M |
XGNExagen Inc | $28.5M |
JNJJohnson & Johnson | $28.0M |
MDXGMiMedx Group Inc | $27.8M |
MISTMilestone Pharmaceuticals In | $25.0M |
TREURTrillium Therapeutics Inc | $22.5M |
TELATela Bio Inc | $20.6M |
I9DNArbutus Biopharma Corp | $19.9M |
BLUBellus Health Inc New | $19.0M |
PMVPPmv Pharmaceuticals Inc | $15.9M |
IMUXImmunic Inc | $14.7M |
BWAYBrainsway Ltd | $14.5M |
RGNXRegenxbio Inc | $14.2M |
BLIUSDBerkeley Lts Inc | $12.9M |
CTMXCytomx Therapeutics Inc | $11.9M |
—Aslan Pharmaceuticals Ltd | $10.9M |
CLSDUSDClearside Biomedical Inc | $10.4M |
—La Jolla Pharmaceutical Co | $9.9M |
—Vincerx Pharma Inc | $9.7M |
INMDInmode Ltd | $9.0M |
ARGXargenx SE | $8.7M |
APVOAptevo Therapeutics Inc | $8.6M |
—Chardan Healthcr Acqstn 2 Co | $8.4M |
CNTBConnect Biopharma Holdings Ltd | $8.3M |
EPIEUREssa Pharma Inc | $8.2M |
SRRKScholar Rock Holding Corp | $8.2M |
MLTXHelix Acquisition Corp | $7.7M |
—Arya Sciences Acquisition Co | $6.9M |
CERE1EURCerevel Therapeutics Hldng I | $6.9M |
—Olink Hldg AB | $6.7M |
—BCTG Acquisition Corp | $6.7M |
—Lifesci Acquisition Ii Corp | $6.6M |
—Research Alliance Corp II | $6.5M |
—Bcls Acquisition Corp | $6.5M |
—Itamar Med Ltd | $6.4M |
AFIBAcutus Med Inc | $6.0M |
RCELAvita Medical Inc | $5.5M |
—Arya Sciences Acqu Corp IV | $5.2M |
—Therapeutics Acquisition Corp | $5.2M |
BOLT1EURBolt Biotherapeutics Inc | $4.9M |
IMTXImmatics N.V | $3.9M |
—5 01 Acquisition Corp | $3.9M |
—Chardan Healthcr Acqstn 2 Co | $3.7M |
PSNLPersonalis Inc | $3.1M |
NUVBNuvation Bio Inc | $3.1M |
—Medicus Sciences Acquisition | $3.0M |
BDSXBiodesix Inc | $2.5M |
MRVIMaravai Lifesciences Hldgs I | $2.5M |
Page 1 of 2Next